Filed: 8/14/2026ACC: 0001213900-26-089935
📋 What this filing means
VIVO CAPITAL, LLC filed this quarterly 13F‑HR report disclosing 47 equity positions with a total reported market value of $1.10B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
47
Positions
$1.10B
Total AUM (reported)
101.77M
Total Shares
Allocation by class
COMMON$940.12M85.8%
SPONSORED ADS$89.54M8.2%
SHS$38.19M3.5%
CLASS A ORD$27.26M2.5%
Portfolio Concentration
Top 3$261.40M23.9%
4–10$312.46M28.5%
11–25$387.27M35.4%
Rest$133.97M12.2%
Top 3 weight
23.9%
Top 10 weight
52.4%
Voting Authority Distribution
Total shares with voting rights: 101.77M
Sole
Full voting authority
101.77M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole47
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings47
Rows:
Trevi Therapeutics Inc
SOLEShares5.09M
TypeSH
Market value$95.02M
8.68%
Sole
5.09M
Shared
0.00
None
0.00
Praxis Precision Medicines
SOLEShares271.12K
TypeSH
Market value$90.77M
8.29%
Sole
271.12K
Shared
0.00
None
0.00
Erasca Inc
SOLEShares4.13M
TypeSH
Market value$75.61M
6.90%
Sole
4.13M
Shared
0.00
None
0.00
Arrivent BioPharma Inc
SOLEShares1.68M
TypeSH
Market value$58.44M
5.34%
Sole
1.68M
Shared
0.00
None
0.00
Abivax SA - ADR
SOLEShares414.90K
TypeSH
Market value$55.29M
5.05%
Sole
414.90K
Shared
0.00
None
0.00
Tango Therapeutics Inc
SOLEShares1.38M
TypeSH
Market value$43.13M
3.94%
Sole
1.38M
Shared
0.00
None
0.00
Corvus Pharmaceuticals Inc
SOLEShares2.81M
TypeSH
Market value$41.92M
3.83%
Sole
2.81M
Shared
0.00
None
0.00
Bright Minds Biosciences Inc
SOLEShares557.17K
TypeSH
Market value$39.11M
3.57%
Sole
557.17K
Shared
0.00
None
0.00
Sinovac Biotech Ltd.
SOLEShares5.90M
TypeSH
Market value$38.19M
3.49%
Sole
5.90M
Shared
0.00
None
0.00
Tenax Therapeutics Inc
SOLEShares2.50M
TypeSH
Market value$36.38M
3.32%
Sole
2.50M
Shared
0.00
None
0.00
Aclaris Therapeutics, Inc.
SOLEShares6.69M
TypeSH
Market value$35.41M
3.23%
Sole
6.69M
Shared
0.00
None
0.00
Dyne Therapeutics Inc
SOLEShares1.56M
TypeSH
Market value$34.59M
3.16%
Sole
1.56M
Shared
0.00
None
0.00
Dianthus Therapeutics Inc
SOLEShares354K
TypeSH
Market value$34.51M
3.15%
Sole
354K
Shared
0.00
None
0.00
Alto Neuroscience Inc
SOLEShares1.21M
TypeSH
Market value$31.90M
2.91%
Sole
1.21M
Shared
0.00
None
0.00
DBV Technologies SA
SOLEShares1.84M
TypeSH
Market value$30.25M
2.76%
Sole
1.84M
Shared
0.00
None
0.00
SAB Biotherapeutics Inc
SOLEShares7.30M
TypeSH
Market value$28.47M
2.60%
Sole
7.30M
Shared
0.00
None
0.00
Moonlake Immunotherapeutics
SOLEShares1.40M
TypeSH
Market value$27.26M
2.49%
Sole
1.40M
Shared
0.00
None
0.00
LB Pharmaceuticals Inc
SOLEShares800K
TypeSH
Market value$25.96M
2.37%
Sole
800K
Shared
0.00
None
0.00
Minerva Neurosciences Inc
SOLEShares4.32M
TypeSH
Market value$23.99M
2.19%
Sole
4.32M
Shared
0.00
None
0.00
Design Therapeutics Inc
SOLEShares1.61M
TypeSH
Market value$23.34M
2.13%
Sole
1.61M
Shared
0.00
None
0.00
Oric Pharmaceuticals Inc
SOLEShares1.85M
TypeSH
Market value$20.02M
1.83%
Sole
1.85M
Shared
0.00
None
0.00
CAMP4 Therapeutics Corporation
SOLEShares4.25M
TypeSH
Market value$18.56M
1.69%
Sole
4.25M
Shared
0.00
None
0.00
Faeth Therapeutics Inc
SOLEShares722.02K
TypeSH
Market value$18.05M
1.65%
Sole
722.02K
Shared
0.00
None
0.00
Achieve Life Sciences Inc.
SOLEShares2.75M
TypeSH
Market value$17.96M
1.64%
Sole
2.75M
Shared
0.00
None
0.00
Compass Therapeutics Inc
SOLEShares7.76M
TypeSH
Market value$16.99M
1.55%
Sole
7.76M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Trevi Therapeutics IncSOLE | Common | 5.09M | SH | $95.02M 8.68% | 5.09M | 0.00 | 0.00 |
Praxis Precision MedicinesSOLE | Common | 271.12K | SH | $90.77M 8.29% | 271.12K | 0.00 | 0.00 |
Erasca IncSOLE | Common | 4.13M | SH | $75.61M 6.90% | 4.13M | 0.00 | 0.00 |
Arrivent BioPharma IncSOLE | Common | 1.68M | SH | $58.44M 5.34% | 1.68M | 0.00 | 0.00 |
Abivax SA - ADRSOLE | SPONSORED ADS | 414.90K | SH | $55.29M 5.05% | 414.90K | 0.00 | 0.00 |
Tango Therapeutics IncSOLE | Common | 1.38M | SH | $43.13M 3.94% | 1.38M | 0.00 | 0.00 |
Corvus Pharmaceuticals IncSOLE | Common | 2.81M | SH | $41.92M 3.83% | 2.81M | 0.00 | 0.00 |
Bright Minds Biosciences IncSOLE | Common | 557.17K | SH | $39.11M 3.57% | 557.17K | 0.00 | 0.00 |
Sinovac Biotech Ltd.SOLE | SHS | 5.90M | SH | $38.19M 3.49% | 5.90M | 0.00 | 0.00 |
Tenax Therapeutics IncSOLE | Common | 2.50M | SH | $36.38M 3.32% | 2.50M | 0.00 | 0.00 |
Aclaris Therapeutics, Inc.SOLE | Common | 6.69M | SH | $35.41M 3.23% | 6.69M | 0.00 | 0.00 |
Dyne Therapeutics IncSOLE | Common | 1.56M | SH | $34.59M 3.16% | 1.56M | 0.00 | 0.00 |
Dianthus Therapeutics IncSOLE | Common | 354K | SH | $34.51M 3.15% | 354K | 0.00 | 0.00 |
Alto Neuroscience IncSOLE | Common | 1.21M | SH | $31.90M 2.91% | 1.21M | 0.00 | 0.00 |
DBV Technologies SASOLE | SPONSORED ADS | 1.84M | SH | $30.25M 2.76% | 1.84M | 0.00 | 0.00 |
SAB Biotherapeutics IncSOLE | Common | 7.30M | SH | $28.47M 2.60% | 7.30M | 0.00 | 0.00 |
Moonlake ImmunotherapeuticsSOLE | Class A ORD | 1.40M | SH | $27.26M 2.49% | 1.40M | 0.00 | 0.00 |
LB Pharmaceuticals IncSOLE | Common | 800K | SH | $25.96M 2.37% | 800K | 0.00 | 0.00 |
Minerva Neurosciences IncSOLE | Common | 4.32M | SH | $23.99M 2.19% | 4.32M | 0.00 | 0.00 |
Design Therapeutics IncSOLE | Common | 1.61M | SH | $23.34M 2.13% | 1.61M | 0.00 | 0.00 |
Oric Pharmaceuticals IncSOLE | Common | 1.85M | SH | $20.02M 1.83% | 1.85M | 0.00 | 0.00 |
CAMP4 Therapeutics CorporationSOLE | Common | 4.25M | SH | $18.56M 1.69% | 4.25M | 0.00 | 0.00 |
Faeth Therapeutics IncSOLE | Common | 722.02K | SH | $18.05M 1.65% | 722.02K | 0.00 | 0.00 |
Achieve Life Sciences Inc.SOLE | Common | 2.75M | SH | $17.96M 1.64% | 2.75M | 0.00 | 0.00 |
Compass Therapeutics IncSOLE | Common | 7.76M | SH | $16.99M 1.55% | 7.76M | 0.00 | 0.00 |
Page 1 of 2